Weight loss pill could replace injections, would be transformative for millions
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
News Medical4d
What's Next for Semaglutide? Beyond Diabetes and Weight Loss
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
CNBC on MSN9d
Healthy Returns: Why people quit weight loss and diabetes drugs within one year
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Ozempic and Blindness: What We Know About Weight Loss Side Effects
Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...
Greek Reporter2d
Popular Weight Loss Drugs Linked to Blindness, New Study Finds
Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.
Nature8d
The weight-loss drugs being tested in 2025: will they beat Ozempic?
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Eli Lilly reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and ...
Ozempic blindness: New study flags unexpected side effect of weight loss drugs
A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...
NBC New York10d
Healthy Returns: Why people quit weight loss and diabetes drugs within one year
Semaglutide is the active ingredient in Novo Nordisk's weight loss drug Wegovy and diabetes counterpart Ozempic, and tirzepatide is the active ingredient in Lilly's obesity injection Zepbound and ...